Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03775694 · ClinicalTrials.gov registry record
Diffusion MRI-1 Imaging Database
A clinical trial, sponsored by Medtronic Spinal and Biologics.
- Completed
- Registry status
- 299
- Enrollment target
NCT03775694: Completed study, sponsored by Medtronic Spinal and Biologics.
NCT03775694 is a clinical trial that has completed, run by Medtronic Spinal and Biologics. The registered enrollment target is 299 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03775694 has completed, sponsored by Medtronic Spinal and Biologics.
- COMPLETED
- Registry status
- 299 participants
- Enrollment target
Study Summary
The purpose of the dMRI-1 data collection study is to establish a database of clinical images and limited medical history information from patients that have previously received a dMRI scan. All data collected will be de-identified. No safety or effectiveness assessments will be completed.
Interventions
- DEVICE dMRI Scan
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 299 participants |
| Start Date | 2019-06-06 |
| Est. Completion | 2022-04-29 |
What the finished NCT03775694 record still lists
NCT03775694 is an observational study that tracks outcomes without assigning an intervention. The registered 299 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which dMRI Scan is the first listed.
NCT03775694 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03775694 about?
NCT03775694 is a clinical study titled "Diffusion MRI-1 Imaging Database". The purpose of the dMRI-1 data collection study is to establish a database of clinical images and limited medical history information from patients that have previously received a dMRI scan. All data collected will be de-identified. No safety or effectiveness assessments will be completed.
What is the current status of trial NCT03775694?
This trial is currently completed. The enrollment target is 299 participants. The study started on 2019-06-06. Estimated completion is 2022-04-29.
What interventions are being tested in trial NCT03775694?
The interventions under investigation include: dMRI Scan (DEVICE).
Who is sponsoring clinical trial NCT03775694?
This trial is sponsored by Medtronic Spinal and Biologics, which has 26 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00353483 · 300 participants
Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells
- NCT00588185 · 300 participants · NA
[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer
- NCT00682032 · 300 participants · NA
The Effect of Beta-glucan in Non-Small Cell Lung Cancer
- NCT00870064 · 300 participants · NA
The Treatment of Type I Open Fractures in Pediatrics
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI